Finance

Lists
Why is 214370 up 2.90%?
Dive Deeper
214370:KOSDAQ
Caregen Co Ltd
â‚©40,850.00
+2.90%
(+1,150.00) 1D
Oct 19, 3:30:16 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214370...
Open
â‚©39,650
High
â‚©40,950
Low
â‚©38,350
Mkt. cap
2.19T
Avg. vol.
66.28K
Volume
49.71K
Dividend
0.98%
Quarterly dividend
â‚©100
Ex-dividend date
Jun 29, 2026
P/E ratio
87.28
52-wk high
â‚©153,800
52-wk low
â‚©36,000
EPS
â‚©468
Shares outstanding
53.72M
No. of employees
209
Open
â‚©39,650
High
â‚©40,950
Low
â‚©38,350
Mkt. cap
2.19T
Avg. vol.
66.28K
Volume
49.71K
Dividend
0.98%
Quarterly dividend
â‚©100
Ex-dividend date
Jun 29, 2026
P/E ratio
87.28
52-wk high
â‚©153,800
52-wk low
â‚©36,000
EPS
â‚©468
Shares outstanding
53.72M
No. of employees
209
News stories
From web sources and news partners
About Caregen Co Ltd
CEO-
Employees209
Founded2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.09B
16.31B
22.70B
18.79B
Cost of goods sold
2.49B
5.92B
7.34B
5.98B
Cost of revenue
2.49B
5.92B
7.34B
5.98B
Research and development expenses
1.39B
1.45B
1.03B
1.10B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.56B
3.17B
3.57B
3.19B
Operating expense
4.74B
17.46B
5.15B
7.58B
Total operating expenses
7.22B
23.38B
12.49B
13.56B
Operating income
9.87B
-7.07B
10.21B
5.24B
Other non operating income
58.90M
148.74M
43.16M
89.35M
EBT including unusual items
12.43B
-4.89B
13.06B
5.93B
EBT excluding unusual items
11.64B
-5.71B
12.92B
5.48B
Income tax expense
2.27B
-1.60B
1.36B
1.63B
Effective tax rate
18.29%
32.83%
10.44%
27.41%
Other operating expenses
250.76M
177.70M
29.79M
13.18M
Net income
10.16B
-3.28B
11.69B
4.30B
Net profit margin
59.43%
-20.12%
51.51%
22.90%
Earnings per share
-
-
-
-
Interest and investment income
91.63M
63.60M
46.67M
50.07M
Interest expense
-
-
-
-
Net interest expenses
91.63M
63.60M
46.67M
50.07M
Depreciation and amortization charges
296.45M
446.50M
270.70M
267.49M
EBITDA
11.09B
-5.70B
11.44B
6.54B
Gain or loss from assets sale
939.00K
910.00K
-1.18M
-614.50M
AI content may include mistakes. Learn more
Google apps